UWM Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Operating income and Adjusted EBITDA remain strong despite a tough mortgage market, with over $3 billion in equity after a record capital raise. The Oaktree partnership brings strategic value, while dividend suspension and reduced debt ratios position the company for long-term growth.
-
Transition to in-house servicing is nearly complete, with strong Q1 origination volume and stable gain on sale margins. Broker channel growth, AI-driven initiatives, and new partnerships are driving operational efficiency and future revenue streams.
Fiscal Year 2025
-
Originations grew 17% to $163.4B in 2025, with strong Q4 results and continued industry leadership. Strategic investments in servicing, technology, and partnerships position the business for further growth, supported by robust capital and liquidity.
-
Q3 2025 saw record loan production and strong financial results, driven by technology investments and a brief rate dip. AI initiatives, especially Mia, boosted refinance volume and operational efficiency. Guidance for Q4 anticipates continued growth and margin strength.
-
Q2 2025 saw $39.7B in production, 20% growth year-over-year, and $314.5M net income. AI-driven tools and in-house servicing initiatives are driving efficiency and future cost savings, with Q3 guidance of $33B–$40B in production and higher margins.
-
Q1 2025 saw 17% year-over-year production growth to $32.4B, with strong broker channel gains and nearly doubled refund volume. Despite a net loss from MSR fair value changes, liquidity remains robust, and guidance targets $38–$45B in Q2 production.
Fiscal Year 2024
-
Production grew 29% to $139.4B in 2024, with net income of $329.4M and record purchase volume despite a tough market. Investments in technology and operational capacity position the company to double originations if rates drop, with strong liquidity and broker channel momentum.
-
Q3 2024 saw record production volume, strong purchase and refi activity, and robust gain margins, with net income achieved despite a large MSR fair value decline. Liquidity remains strong, technology adoption is rising, and guidance for Q4 is confident amid ongoing market uncertainty.
-
Q2 2024 saw production rise 22% sequentially and 6% year-over-year, with net income over $76M despite MSR fair value declines. Technology investments and MSR sales have positioned the company for scalable growth, with strong liquidity and upside potential if rates drop.